CClinicalTrials.gg
Status unknownNCT02621138Updated Apr 8, 2016

The Influence of Muscle Contraction on the Cardiac Autonomic System

An observational study in Cerebral Palsy, sponsored by Alyn Pediatric & Adolescent Rehabilitation Hospital. Status unknown at 1 site in Israel. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-08.

Sponsored by Alyn Pediatric & Adolescent Rehabilitation Hospital · Observational

The sponsor has not verified this record recently (last verified Nov 2015), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
32
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Population:

16 children with cerebral palsy, GMFCS 1-3.16 children typically developed, matched for age.

All children aged 6-12 yrs who understand simple commands.

Tools:

  1. Polar monitor to record heart rate, attached to chest, in use throughout testing
  2. Dynamometer- for assessing muscle strength.
  3. Weights

Method:

Each child will be tested once. Both tools will be demonstrated and tried out before actual testing.

With Polar watch attached:

  1. 5 min sitting at rest,
  2. knee muscle strength assessment with the dynamometer,
  3. 15 minutes rest
  4. Isometric and isotonic knee muscle contraction at 30% of childs' maximal strength as has assessed by the dynamometer. The child will asked to perform each for 3 minutes, with 5 minutes rest in-between All will be perform in both legs.
02

Conditions studied

  • Cerebral Palsy

Browse trials for

03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's planned enrollment of 32 is below the median of 63 across 455 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Alyn Pediatric & Adolescent Rehabilitation Hospital is the lead sponsor of 12 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

children with cerebral palsy

Inclusion criteria

  • GMFCS I-II
  • Unilateral CP

Exclusion criteria

Exclusion Criteria:

  • Heart problems
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
32 participants (estimated)
Patient registry
No

Groups and cohorts

  • cerebral palsy

    Age 6-12 years Gross Motor Function Classification System I-II

  • control

    Age 6-12 years

06

What researchers measure

Primary outcomes

  1. Heart rate

    Time frame: 40 minutes

  2. Heart rate variability

    Time frame: 40 minutes

07

Study locations

1 site
  • Alyn Children's Rehabilitation Hospital
    Jerusalem, 91090, Israel
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02621138
Lead sponsor
Alyn Pediatric & Adolescent Rehabilitation Hospital
Responsible party
Sponsor
First posted
Dec 3, 2015
Start date
Apr 2016
Primary completion
Dec 2016 (estimated)
Last update
Apr 8, 2016

Study contacts

Michal Katz
Contact
mkatz@alyn.org

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion